tirzepatide mash fda FDA approved Madrigal's Resmetirom (Rezdiffra®) as first drug treatment for MASH. What now? Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis
Pay in 4 interest-free payments of $6.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29





























